Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleADULT BRAIN

Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study

A. Jena, S. Taneja, A. Jha, N.K. Damesha, P. Negi, G.K. Jadhav, S.M. Verma and S.K. Sogani
American Journal of Neuroradiology May 2017, 38 (5) 899-907; DOI: https://doi.org/10.3174/ajnr.A5124
A. Jena
aFrom the PET SUITE (A. Jena, S.T., A. Jha, P.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Jena
S. Taneja
aFrom the PET SUITE (A. Jena, S.T., A. Jha, P.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Taneja
A. Jha
aFrom the PET SUITE (A. Jena, S.T., A. Jha, P.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Jha
N.K. Damesha
cNeurosurgery (N.K.D., S.K.S.), Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for N.K. Damesha
P. Negi
aFrom the PET SUITE (A. Jena, S.T., A. Jha, P.N.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Negi
G.K. Jadhav
bDepartments of Molecular Imaging and Nuclear Medicine, Radiation Oncology (G.K.J., S.M.V.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G.K. Jadhav
S.M. Verma
bDepartments of Molecular Imaging and Nuclear Medicine, Radiation Oncology (G.K.J., S.M.V.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.M. Verma
S.K. Sogani
cNeurosurgery (N.K.D., S.K.S.), Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi, India.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.K. Sogani
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

REFERENCES

  1. 1.↵
    1. Chamberlain MC,
    2. Glantz MJ,
    3. Chalmers L, et al
    . Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 2007;82:81–83 doi:10.1007/s11060-006-9241-y pmid:16944309
    CrossRefPubMed
  2. 2.↵
    1. Brandes AA,
    2. Franceschi E,
    3. Tosoni A, et al
    . MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008;26:2192–97 doi:10.1200/JCO.2007.14.8163 pmid:18445844
    Abstract/FREE Full Text
  3. 3.↵
    1. Chan JL,
    2. Lee SW,
    3. Fraass BA, et al
    . Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002;20:1635–42 doi:10.1200/JCO.20.6.1635 pmid:11896114
    Abstract/FREE Full Text
  4. 4.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Tomiguchi S, et al
    . Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901–09 pmid:10815666
    Abstract/FREE Full Text
  5. 5.↵
    1. Brandsma D,
    2. Stalpers L,
    3. Taal W, et al
    . Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008;9:453–61 doi:10.1016/S1470-2045(08)70125-6 pmid:18452856
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. Alexiou GA,
    2. Tsiouris S,
    3. Kyritsis AP, et al
    . Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 2009;95:1–11 doi:10.1007/s11060-009-9897-1 pmid:19381441
    CrossRefPubMed
  7. 7.↵
    1. Heiss W,
    2. Raab P,
    3. Lanfermann H
    . Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med 2011;52:1585–600 doi:10.2967/jnumed.110.084210 pmid:21840931
    Abstract/FREE Full Text
  8. 8.↵
    1. Keunen O,
    2. Taxt T,
    3. Grüner R, et al
    . Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. Adv Drug Deliv Rev 2014;76:98–115 doi:10.1016/j.addr.2014.07.010 pmid:25078721
    CrossRefPubMed
  9. 9.↵
    1. Wang X,
    2. Hu X,
    3. Xie P, et al
    . Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: a diagnostic meta-analysis. Asia Pac J Clin Oncol 2015;11:97–105 doi:10.1111/ajco.12202 pmid:24783970
    CrossRefPubMed
  10. 10.↵
    1. Nihashi T,
    2. Dahabreh IJ,
    3. Terasawa T
    . Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. AJNR Am J Neuroradiol 2013;34:944–50, S1–11 doi:10.3174/ajnr.A3324 pmid:23124638
    Abstract/FREE Full Text
  11. 11.↵
    1. Huang RY,
    2. Neagu MR,
    3. Reardon DA, et al
    . Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy: detecting illusive disease, defining response. Front Neurol 2015;6:33 doi:10.3389/fneur.2015.00033 pmid:25755649
    CrossRefPubMed
  12. 12.↵
    1. Estrada G,
    2. González-Maya L,
    3. Celis-López MA, et al
    . Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections: first experience in Mexico. Rev Esp Med Nucl 2008;27:329–39 doi:10.1157/13126189 pmid:18817662
    CrossRefPubMed
  13. 13.↵
    1. Seeger A,
    2. Braun C,
    3. Skardelly M, et al
    . Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease. Acad Radiol 2013;20:1557–65 doi:10.1016/j.acra.2013.09.003 pmid:24200483
    CrossRefPubMed
  14. 14.↵
    1. Di Costanzo A,
    2. Scarabino T,
    3. Trojsi F, et al
    . Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. Radiol Med 2014;119:616–24 doi:10.1007/s11547-013-0371-y pmid:24408041
    CrossRefPubMed
  15. 15.↵
    1. Enslow MS,
    2. Zollinger LV,
    3. Morton KA, et al
    . Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med 2012;37:854–61 doi:10.1097/RLU.0b013e318262c76a pmid:22889774
    CrossRefPubMed
  16. 16.↵
    1. Nozawa A,
    2. Rivandi AH,
    3. Kanematsu M, et al
    . Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes. Nucl Med Commun 2015;36:573–81 doi:10.1097/MNM.0000000000000288 pmid:25714806
    CrossRefPubMed
  17. 17.↵
    1. Ellingson BM,
    2. Kim HJ,
    3. Woodworth DC, et al
    . Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 2014;271:200–10 doi:10.1148/radiol.13131305 pmid:24475840
    CrossRefPubMedWeb of Science
  18. 18.↵
    1. Kim ES,
    2. Satter M,
    3. Reed M, et al
    . A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma. Neuroradiol J 2016;29:193–97 doi:10.1177/1971400916639962 pmid:27122050
    CrossRefPubMed
  19. 19.↵
    1. Peca C,
    2. Pacelli R,
    3. Elefante A, et al
    . Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? Clin Neurol Neurosurg 2009;111:331–34 doi:10.1016/j.clineuro.2008.11.003 pmid:19117668
    CrossRefPubMed
  20. 20.↵
    1. Hygino Da Cruz LC,
    2. Rodriguez I,
    3. Domingues RC, et al
    . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85 doi:10.3174/ajnr.A2397 pmid:21393407
    Abstract/FREE Full Text
  21. 21.↵
    1. Garibotto V,
    2. Heinzer S,
    3. Vulliemoz S, et al
    . Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med 2013;38:e13–18 doi:10.1097/RLU.0b013e3182638ea6 pmid:23242058
    CrossRefPubMed
  22. 22.↵
    1. Prager AJ,
    2. Martinez N,
    3. Beal K, et al
    . Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol 2015;36:877–85 doi:10.3174/ajnr.A4218 pmid:25593202
    Abstract/FREE Full Text
  23. 23.↵
    1. Ozsunar Y,
    2. Mullins ME,
    3. Kwong K, et al
    . Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol 2010;17:282–90 doi:10.1016/j.acra.2009.10.024 pmid:20060750
    CrossRefPubMed
  24. 24.↵
    1. Deng SM,
    2. Zhang B,
    3. Wu YW, et al
    . Detection of glioma recurrence by 11C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis. Nucl Med Commun 2013;34:758–66 doi:10.1097/MNM.0b013e328361f598 pmid:23670103
    CrossRefPubMed
  25. 25.↵
    1. Gahramanov S,
    2. Raslan AM,
    3. Muldoon LL, et al
    . Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int J Radiat Oncol Biol Phys 2011;79:514–23 doi:10.1016/j.ijrobp.2009.10.072 pmid:20395065
    CrossRefPubMed
  26. 26.↵
    1. Fink JR,
    2. Carr RB,
    3. Matsusue E, et al
    . Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. J Magn Reson Imaging 2012;35:56–63 doi:10.1002/jmri.22801 pmid:22002882
    CrossRefPubMed
  27. 27.↵
    1. Matsusue E,
    2. Fink JR,
    3. Rockhill JK, et al
    . Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 2010;52:297–306 doi:10.1007/s00234-009-0613-9 pmid:19834699
    CrossRefPubMedWeb of Science
  28. 28.↵
    1. Mong S,
    2. Ellingson BM,
    3. Nghiemphu PL, et al
    . Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls. AJNR Am J Neuroradiol 2012;33:1763–70 doi:10.3174/ajnr.A3053 pmid:22538078
    Abstract/FREE Full Text
  29. 29.↵
    1. Werner P,
    2. Rullmann M,
    3. Bresch A, et al
    . Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRI. EJNMMI Res 2016;6:47 doi:10.1186/s13550-016-0200-0 pmid:27255510
    CrossRefPubMed
  30. 30.↵
    1. McGirt MJ,
    2. Woodworth GF,
    3. Coon AL, et al
    . Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005;102:897–901 doi:10.3171/jns.2005.102.5.0897 pmid:15926716
    CrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 38 (5)
American Journal of Neuroradiology
Vol. 38, Issue 5
1 May 2017
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
A. Jena, S. Taneja, A. Jha, N.K. Damesha, P. Negi, G.K. Jadhav, S.M. Verma, S.K. Sogani
Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
American Journal of Neuroradiology May 2017, 38 (5) 899-907; DOI: 10.3174/ajnr.A5124

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous 18F-FDG-PET/MRI: A Single-Institution Retrospective Study
A. Jena, S. Taneja, A. Jha, N.K. Damesha, P. Negi, G.K. Jadhav, S.M. Verma, S.K. Sogani
American Journal of Neuroradiology May 2017, 38 (5) 899-907; DOI: 10.3174/ajnr.A5124
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis
  • Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature
  • Crossref (45)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
    Anastasia Zikou, Chrissa Sioka, George A. Alexiou, Andreas Fotopoulos, Spyridon Voulgaris, Maria I. Argyropoulou
    Contrast Media & Molecular Imaging 2018 2018
  • Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI
    Thomas Pyka, Daniela Hiob, Christine Preibisch, Jens Gempt, Benedikt Wiestler, Jürgen Schlegel, Christoph Straube, Claus Zimmer
    European Journal of Radiology 2018 103
  • Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors
    Wynton B. Overcast, Korbin M. Davis, Chang Y. Ho, Gary D. Hutchins, Mark A. Green, Brian D. Graner, Michael C. Veronesi
    Current Oncology Reports 2021 23 3
  • Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review
    Motomasa Furuse, Naosuke Nonoguchi, Kei Yamada, Tohru Shiga, Jean-Damien Combes, Naokado Ikeda, Shinji Kawabata, Toshihiko Kuroiwa, Shin-Ichi Miyatake
    Radiation Oncology 2019 14 1
  • Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model
    Kai Wang, Zhen Qiao, Xiaobin Zhao, Xiaotong Li, Xin Wang, Tingfan Wu, Zhongwei Chen, Di Fan, Qian Chen, Lin Ai
    European Journal of Nuclear Medicine and Molecular Imaging 2020 47 6
  • Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology
    Sebastian F Winter, Franziska Loebel, Jay Loeffler, Tracy T Batchelor, Maria Martinez-Lage, Peter Vajkoczy, Jorg Dietrich
    Neuro-Oncology 2019 21 9
  • Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers
    Clara Le Fèvre, Jean-Marc Constans, Isabelle Chambrelant, Delphine Antoni, Caroline Bund, Benjamin Leroy-Freschini, Roland Schott, Hélène Cebula, Georges Noël
    Critical Reviews in Oncology/Hematology 2021 159
  • Diagnostic Accuracy of PET for Differentiating True Glioma Progression From Post Treatment-Related Changes: A Systematic Review and Meta-Analysis
    Meng Cui, Rocío Isabel Zorrilla-Veloz, Jian Hu, Bing Guan, Xiaodong Ma
    Frontiers in Neurology 2021 12
  • Differentiation of Recurrence from Radiation Necrosis in Gliomas Based on the Radiomics of Combinational Features and Multimodality MRI Images
    Quan Zhang, Jianyun Cao, Junde Zhang, Junguo Bu, Yuwei Yu, Yujing Tan, Qianjin Feng, Meiyan Huang
    Computational and Mathematical Methods in Medicine 2019 2019
  • International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
    Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, Roberto C. Delgado Bolton, Swen Hesse, Thomas Hope, Martin W. Huellner, Andrei Iagaru, Geoffrey B. Johnson, Andreas Kjaer, Ian Law, Ur Metser, Harald H. Quick, Bernhard Sattler, Lale Umutlu, Greg Zaharchuk, Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 12

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Clinical Outcomes After Chiari I Decompression
  • Segmentation of Brain Metastases with BLAST
Show more ADULT BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire